# Nephrology Consultation

> **SYNTHETIC RECORD, NOT A REAL MEDICAL RECORD**

- Patient: Emily Dickinson (real historical name used in a fictional teaching record)
- Synthetic MRN: HR-NI023-SYN-TD
- Date: 1885-02-02
- Fictional facility: St. Posthumous Health Center
- Fictional author: Samuel Adeyemi, MD
- Calendar frame: true historical dates (modern content is anachronistic)

> True-date frame: synthetic events are moved into the patient's historical lifetime. Codes, instruments, and treatments remain modern and are anachronistic.

- Requested by: Lucinda Hartwell, MD

## Reason for consultation

Stage G3a A2 chronic kidney disease with hypertension in a 54-year-old woman without diabetes. Please confirm the probable cause, advise whether further tests are needed, and advise on kidney-protective treatment and follow-up. **S**

## History

Ms. Dickinson is seen at the request of Dr. Hartwell for chronic kidney disease with albuminuria and newly treated hypertension. She has had morning headaches and nausea for several months and took naproxen for them until three weeks ago. A low eGFR and albuminuria were found fourteen months ago and not followed up, so the disease has lasted more than three months. She has no history of kidney disease in childhood, urinary infections, stones, rash, joint pain, or blood in the urine, and no diabetes. She takes no herbal remedies or proton pump inhibitors. She started losartan 50 mg three weeks ago. **S**

## Examination

| System | Finding |
|---|---|
| Vital signs | 148/88 mmHg seated after five minutes' rest, average of two readings; pulse 74 |
| Cardiovascular | Regular rhythm; no murmur; no edema |
| Abdomen | Soft; kidneys not palpable; no renal bruit |
| Skin and joints | No rash, purpura, or synovitis |

BP 148/88 mmHg; pulse 74 bpm; respirations 14/min; temperature 36.5 °C; oxygen saturation 98% on room air; weight 53.8 kg; BMI 20.2 kg/m². All vital signs are synthetic.

## Data reviewed

The intake results, the ECG, today's metabolic panel and second urine albumin-creatinine ratio, home blood pressure readings, and this morning's kidney ultrasound. Sodium: 140 mmol/L; Potassium: 4.6 mmol/L; Bicarbonate (total CO2): 24 mmol/L; BUN: 22 mg/dL (high); Creatinine: 1.26 mg/dL (high); eGFR: 51 mL/min/1.73 m² (low); Glucose: 90 mg/dL; Urine albumin-creatinine ratio: 262 mg/g (high). All results are synthetic.

## Assessment

1. **Chronic kidney disease G3a A2** (N18.31). Confirmed: eGFR 51 to 58 for more than three months, with albuminuria of 240 and 262 mg/g on two samples. Long-standing untreated hypertension, borderline left ventricular hypertrophy on ECG, a bland urine without red cells, and normal-sized, mildly echogenic kidneys on ultrasound make hypertensive kidney disease the probable cause, possibly worsened by regular naproxen. With no hematuria, systemic features, nephrotic-range albuminuria, or rapid decline, a biopsy or glomerular serology is not needed now. KFRE is low, at 1.6 percent over 5 years. **S**
2. **Hypertension with chronic kidney disease** (I12.9). Above target on losartan 50 mg. Today's potassium of 4.6 mmol/L and creatinine of 1.26 mg/dL after three weeks allow the dose to be raised. **S**
3. **Vitamin D deficiency with a mildly raised PTH** (E55.9). A PTH of 74 pg/mL at G3a with a low vitamin D is most likely from the vitamin D deficiency; calcium and phosphate are normal. **S**

## Recommendations

1. Raise losartan to 100 mg daily, the maximum dose, for A2 albuminuria.
2. Start dapagliflozin 10 mg daily: KDIGO recommends an SGLT2 inhibitor in chronic kidney disease with eGFR of at least 20 and a urine albumin-creatinine ratio of at least 200 mg/g, with or without diabetes.
3. Recheck potassium and creatinine 2 to 4 weeks after these changes; accept a creatinine rise of up to 30 percent.
4. Aim for a standardized systolic pressure below 120 mmHg if tolerated; if home readings stay above target on the full ARB dose, add amlodipine.
5. Repeat the urine albumin-creatinine ratio about three months after starting treatment to judge the response, then eGFR and urine albumin twice a year.
6. Continue vitamin D3 1,000 units daily and recheck 25-hydroxyvitamin D, calcium, phosphate, and PTH in 6 to 12 months; no calcitriol.
7. No NSAIDs; written sick-day rules for losartan and dapagliflozin during vomiting, diarrhea, or poor intake.
8. Complete hepatitis B vaccination, as for all adults with chronic kidney disease.

## Strengths and supports

- Supports: her household, a few close friends she writes to often, and her work **S**

## Communication

Discussed with Dr. Hartwell the same morning. Ms. Dickinson agrees with the plan and asked for it in writing. **S**

## Follow-up

Primary care leads, with home and video visits. Nephrology video review in about a year with the yearly tests, or sooner if eGFR falls by more than 20 percent and stays down, the urine albumin-creatinine ratio doubles, potassium is above 5.5 mmol/L, or the 5-year KFRE reaches 3 percent. **S**

## Guideline basis

- KDIGO 2024 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease (2024), Kidney Disease: Improving Global Outcomes (Kidney Int 2024;105(4S):S117-S314)
- KDIGO 2021 Clinical Practice Guideline for the Management of Blood Pressure in Chronic Kidney Disease (2021), Kidney Disease: Improving Global Outcomes (Kidney Int 2021;99(3S):S1-S87)
- CMID: Clinical Monitoring Intelligence Database, chronic kidney disease, hypertension, and depression monographs (2026), Aether Forge
